SCHEMBL10510

SCHEMBL10510

CC(Br)CCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8711359 0.83
Furan SCHEMBL28035970 0.82 MAPK1 (0.32)
SCHEMBL24182240 0.76 USP2 (0.30)
SCHEMBL107778 0.75
SCHEMBL17381336 0.75 ALDH1A1 (0.42)
SCHEMBL27481903 0.75
SCHEMBL1010069 0.73
SCHEMBL7844269 0.73
Ethane SCHEMBL3782667 0.73
Methane SCHEMBL782703 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493310-A1 BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS GlaxoSmithKline LLC (US) 2012-09-05 EP disclosed
US-20120208827-A1 BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC 2012-08-16 US disclosed
WO-2011056635-A1 BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed
EP-1087941-B9 THIOLESTERS AND USES THEREOF US HEALTH (US) 2007-11-07 EP disclosed
EP-1087941-B1 THIOLESTERS AND USES THEREOF US HEALTH (US) 2006-08-16 EP disclosed
US-6706729-B1 A METHOD FOR DISSOCIATING A METAL ION FROM A ZINC FINGER-CONTAINING PROTEIN; INHIBITING VIRUS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2004-03-16 US disclosed
EP-0890663-B1 Improved regenerated collagen fiber and method of manufacturing the same KANEKA CORP (JP) 2002-11-13 EP disclosed
EP-1087941-A2 THIOLESTERS AND USES THEREOF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 2001-04-04 EP disclosed
US-6160096-A Regenerated collagen fiber and method of manufacturing the same KANEKA CORPORATION (JP) 2000-12-12 US disclosed
WO-1999065871-A2 THIOLESTERS AND USES THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-23 WO disclosed
EP-0890663-A2 Improved regenerated collagen fiber and method of manufacturing the same Kaneka Corporation (JP) 1999-01-13 EP disclosed